Climb Bio, Inc. — Form D/A

Climb Bio, Inc. of WELLESLEY HILLS, MA, a company, filed a Form D amendment with the SEC on 2019-10-23. The offering totals $16.3M, of which $16.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Andrew LevinDirectorBOSTON, MA
Andrew LevinExecutive OfficerBOSTON, MA
Andrew LevinRelated PersonBOSTON, MA
Stephen ThomasDirectorDallas, TX
Stephen ThomasRelated PersonDallas, TX
Julio VegaExecutive OfficerCambridge, MA
Erin LavelleExecutive OfficerCharlottesville, VA
Liam RatcliffeDirectorNew York, NY
Adam RosenbergDirectorWilmington, DE
Simon TateDirectorWilmington, DE
Aoife BrennanDirectorWellesley Hills, MA
Aoife BrennanExecutive OfficerWellesley Hills, MA
Aoife BrennanRelated PersonWellesley Hills, MA
Judith DunnDirectorWellesley Hills, MA
Judith DunnRelated PersonWellesley Hills, MA
Valerie MorissetExecutive OfficerWilmington, DE
David-Alexandre GrosDirectorIrvine, CA
Douglas WilliamsRelated PersonWellesley Hills, MA
Robert AzelbyDirectorRedmond, WA
Robert AzelbyExecutive OfficerRedmond, WA
James BucherExecutive OfficerRedmond, WA
Leone PattersonDirectorRedmond, WA
Harald StockDirectorPark City, UT
Susan AltschullerRelated PersonWellesley Hills, MA
Perrin WilsonRelated PersonWellesley Hills, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2026-05-04D$110.1M$110.1M
2024-07-02D$120.0M$120.0M
2024-07-02D$41.9M$41.9M
2021-05-28D$60.0M$60.0M
2020-11-03D$50.0M$5.0M
2019-10-23D$10.0M$10.0M
2019-02-19D$12.2M$12.2M

More